MWP
RPRX icon

MYCIO Wealth Partners’s Royalty Pharma RPRX Stock Holding History

MYCIO Wealth Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-113,652
Closed -$3.45M – 47
2024
Q1 		$3.45M Hold
113,652
– – 0.87% 16
2023
Q4 		$3.19M Hold
113,652
– – 0.9% 17
2023
Q3 		$3.08M Buy
+113,652
New +$3.38M 0.92% 15

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MYCIO Wealth Partners's RPRX Position: Q2 2024 in Review

MYCIO Wealth Partners sold out of Royalty Pharma (RPRX) in Q2 2024, closing a stake of 113,652 shares — an estimated $3.45M sold.

MYCIO Wealth Partners first reported a position in RPRX in Q3 2023 and held it in 3 quarters. The position peaked at $3.45M in Q1 2024. 378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • MYCIO Wealth Partners reported no remaining Royalty Pharma position as of Q2 2024 after selling out during the quarter.
  • MYCIO Wealth Partners sold 113,652 Royalty Pharma shares in Q2 2024, an estimated $3.45M.
  • MYCIO Wealth Partners first reported a position in Royalty Pharma in Q3 2023 and held it in 3 quarters.
  • MYCIO Wealth Partners's Royalty Pharma position peaked at $3.45M in Q1 2024.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on MYCIO Wealth Partners's 13F filing for Q2 2024, filed 12 Aug 2024.